Zhenzhong Zhang

Zhenzhong Zhang

Auto-generated profile, based on publicly available information

Zhenzhong Zhang

Department of Obstetrics and Gynecology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2019 in Bioorganic & Medicinal Chemistry
Verified
Journal Article
Closed access
BLBingnan Liu
Bingnan Liu
ZZZhenzhong Zhang
Zhenzhong Zhang
HWHao Wang
Hao Wang
SYShaobo Yao
Shaobo Yao

13 March 2020 in Clinical Cancer Research
Verified
Journal Article
Closed access
PDF file
FLFei Li
Fei Li
ZZZhenzhong Zhang
Zhenzhong Zhang
JCJiong Cai
Jiong Cai
XCXi Chen
Xi Chen
YZYing Zhou
Ying Zhou
LXLing Xi
Ling Xi
Purpose: Tumor periphery and lymph nodes of tumor-induced lymphangiogenesis often abundantly express vascular endothelial growth factor receptor-3 (VEGFR-3). In our previous study, we identified a 5-amino acid peptide named TMVP1, which binds specifically to VEGFR-3. The objective of the present study was to develop a novel 68Ga-labeled TMVP1 for VEGFR-3 PET imaging and to investigate its safety, biodistribution, and tumor-localizing efficacy in xenograft tumor models and a small cohort of patients with recurrent ovarian and cervical cancer. Experimental Design: The DOTA-conjugated TMVP1 peptide was labeled with radionuclide 68Ga. SPR and saturation binding assays were used for the receptor-binding studies. Gynecological xenograft tumors were employed for small-animal PET imaging and biodistribution of 68Ga-DOTA-TMVP1 in vivo. In the clinical study, five healthy volunteers and eight gynecological cancer patients underwent whole-body PET/CT after being injected with 68Ga-DOTA-TMVP1. Results: DOTA-TMVP1 was successfully labeled with 68Ga. LECs showed higher binding capacity with 68Ga-DOTA-TMVP1 than LEC(shVEGFR-3) and HUVECs. In mice with subcutaneous C33-A and SKOV-3 xenografts, the tracer was rapidly eliminated through the kidney to the bladder, and the small-animal PET/CT helped to clearly visualize the tumors. In patients with recurrent ovarian cancer and cervical cancer, tracer accumulation well above the background level was demonstrated in most identified sites of disease; especially with recurrent endodermal sinus tumors, the diagnostic value of 68Ga-DOTA-TMVP1 was comparable to that of 18F-FDG PET/CT. Conclusions: 68Ga-DOTA-TMVP1 is a potential PET tracer for imaging VEGFR-3 with favorable pharmacokinetics.

9 August 2015 in Amino Acids
Verified
Journal Article
Closed access
PDF file
FLFei Li
Fei Li
ZZZhenzhong Zhang
Zhenzhong Zhang
TCTeng Cheng
Teng Cheng
RWRui Wei
Rui Wei
YDYun Dai
Yun Dai
XMXiangyi Ma
Xiangyi Ma